Kezar Life Sciences
50 hedge funds and large institutions have $176M invested in Kezar Life Sciences in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
20% less capital invested
Capital invested by funds: $220M → $176M (-$44.5M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
50
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$7.13M | |
| 2 | +$6.91M | |
| 3 | +$4.18M | |
| 4 |
SC
Slow Capital
Greenbrae,
California
|
+$3.48M |
| 5 |
FM
Frazier Management
Seattle,
Washington
|
+$2.13M |
Top Sellers
| 1 | -$15.9M | |
| 2 | -$6.05M | |
| 3 | -$3.61M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$2.18M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.65M |